Steven Naymagon, MD
img_Steven Naymagon
ASSISTANT CLINICAL PROFESSOR | Medicine, Gastroenterology
Are you a patient?
Specialties
Internal Medicine, Gastroenterology

MD, Icahn School of Medicine at Mount Sinai

MD, Mount Sinai School of Medicine

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Gastroenterology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms. Alexandra E. Livanos, Divya Jha, Francesca Cossarini, Ana S. Gonzalez-Reiche, Minami Tokuyama, Teresa Aydillo, Tommaso L. Parigi, Mark S. Ladinsky, Irene Ramos, Katie Dunleavy, Brian Lee, Rebekah E. Dixon, Steven T. Chen, Gustavo Martinez-Delgado, Satish Nagula, Emily A. Bruce, Huaibin M. Ko, Benjamin S. Glicksberg, Girish Nadkarni, Elisabet Pujadas, Jason Reidy, Steven Naymagon, Ari Grinspan, Jawad Ahmad, Michael Tankelevich, Yaron Bram, Ronald Gordon, Keshav Sharma, Jane Houldsworth, Graham J. Britton, Alice Chen-Liaw, Matthew P. Spindler, Tamar Plitt, Pei Wang, Andrea Cerutti, Jeremiah J. Faith, Jean Frederic Colombel, Ephraim Kenigsberg, Carmen Argmann, Miriam Merad, Sacha Gnjatic, Noam Harpaz, Silvio Danese, Carlos Cordon-Cardo, Adeeb Rahman, Robert E. Schwartz, Nikhil A. Kumta, Alessio Aghemo, Pamela J. Bjorkman, Francesca Petralia, Harm van Bakel, Adolfo Garcia-Sastre, Saurabh Mehandru. Gastroenterology

The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients with Inflammatory Bowel Disease. Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Steven Naymagon, John Mascarenhas, Thomas Schiano. Inflammatory Bowel Diseases

Severe Protein-Losing Enteropathy Due to an Indolent Splenic Lymphoma: Case Report and Review of the Literature. Leonard Naymagon, Stephen Ward, Steven Naymagon, Shyamala Navada. Clinical Lymphoma, Myeloma and Leukemia

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Naymagon has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.